Vidyya Medical News Service
Volume 5 Issue 210 Published - 14:00 UTC 08:00 EST 29-July-2003 Next Update - 14:00 UTC 08:00 EST 30-July-2003
little clear gif used for spacer

FDA approves Humatrope for short stature
The Food and Drug Administration (FDA) today approved a new indication for Humatrope (Somatropin, rDNA origin, for injection), a brand of growth hormone, for the long-term treatment of children with idiopathic (of unknown origin) short stature, also called non-growth hormone deficient short stature.  more

Prescribing information: Humatrope
Humatrope Prescribing Information is available for download in Portable Document Format (PDF). You will need Adobe's Acrobat Reader software to read the full prescribing information.  more


FDA approves enbrel to treat ankylosing spondylitis
FDA today approved an application for etanercept (trade-name Enbrel), a genetically engineered protein, for a new indication for treatment of patients with active ankylosing spondylitis (AS), a chronic inflammatory disease affecting primarily the lower back and joints.  more

Type 2 diabetes linked to a family of metabolic genes
An ambitious and exhaustive genetic study, led by investigators at the Joslin Diabetes Center and the Children's Hospital Boston Informatics Program, has pinpointed a group of genes that are involved in type 2 diabetes and shows that the activity of these genes changes even before overt diabetes develops. more

Common misperceptions of bipolar disorder may lead to misdiagnosis in children
Aiming to gain a better understanding of the public's perceptions of bipolar disorder (manic-depression), a recent survey revealed that only 11 percent of adults believe the illness can occur at any age and only 40 percent believe it is hereditary -- two common misperceptions that may lead to misdiagnosis in children.  more

little clear gif used for a space